ENO2 and non-small cell lung carcinoma: Graphene biosensors are designed to detect specific biomarkers for tumors, including EGFR, TP53, KRAS, neuron-specific enolase (NSE), CYFRA 21–1, and carcinoembryonic antigen (CEA), which are important in the diagnosis and follow-up of NSCLC diseases.